showed that human CLL cells and CLL-like CD5+ B cells from Eμ-TCL1 mice, which we have shown to be CD21− [18], can be stimulated to express IL10 by LPS + PIM treatment in vitro [8]. The gene discussed is IL10; the disease is B-cell chronic lymphocytic leukemia.